KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Biomarin Pharmaceutical (BMRN) over the last 15 years, with Q4 2024 value amounting to $4.5 million.

  • Biomarin Pharmaceutical's Treasury Shares fell 355.25% to $4.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.5 million, marking a year-over-year decrease of 355.25%. This contributed to the annual value of $4.5 million for FY2024, which is 355.25% down from last year.
  • According to the latest figures from Q4 2024, Biomarin Pharmaceutical's Treasury Shares is $4.5 million, which was down 355.25% from $4.7 million recorded in Q4 2023.
  • In the past 5 years, Biomarin Pharmaceutical's Treasury Shares ranged from a high of $4.7 million in Q4 2023 and a low of $126710.0 during Q1 2020
  • Over the past 5 years, Biomarin Pharmaceutical's median Treasury Shares value was $518000.0 (recorded in 2020), while the average stood at $2.2 million.
  • Per our database at Business Quant, Biomarin Pharmaceutical's Treasury Shares surged by 75666.25% in 2021 and then plummeted by 355.25% in 2024.
  • Biomarin Pharmaceutical's Treasury Shares (Quarter) stood at $518000.0 in 2020, then surged by 756.66% to $4.4 million in 2021, then grew by 1.85% to $4.5 million in 2022, then increased by 4.07% to $4.7 million in 2023, then dropped by 3.55% to $4.5 million in 2024.
  • Its Treasury Shares stands at $4.5 million for Q4 2024, versus $4.7 million for Q4 2023 and $4.5 million for Q4 2022.